Testing effectiveness (Phase 2)Study completedNCT00344773
What this trial is testing
First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation
Who this might be right for
Pulmonary Cancer
AstraZeneca 46
Showing 20 of 0 results